---
title: BioAgile Therapeutics vs Indero
slug_a: bioagiletherapeutics
slug_b: inderocro
site: cro
review_signal_gate: closed
canonical_path: /compare/bioagiletherapeutics/inderocro
---

# BioAgile Therapeutics vs Indero

Side-by-side profile data from each company listing on this directory.

## BioAgile Therapeutics

- Profile: [/companies/bioagiletherapeutics](/companies/bioagiletherapeutics)

BioAgile Therapeutics — ISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech.

Services: 10. Modalities: 0. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (10).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)

## Indero

- Profile: [/companies/inderocro](/companies/inderocro)

Indero — Indero is a dual-focus CRO specializing in dermatology and rheumatology clinical trials, offering end-to-end services from early to late phase with global capabilities across North America, Europe, Latin America, and Asia-Pacific.

Services: 11. Modalities: 0. Indications: 2. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- Translational Research

### Modalities

- Data not yet provided.

### Indications

- Immunology
- Dermatology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)